VRTX — Vertex Pharmaceuticals Incorporated | Setup 20-24 Jul 2026
VRTX
Vertex Pharmaceuticals Incorporated
📅 Earnings · Jul 30, 2026 · in 5d
SCORE IQS Lite
60/100
Weekly Structure 22
Daily Momentum 13
Weekly Ichimoku 19
Daily CMF 3
Delta 3
IQS Lite components · score
IQS Lite analysis - AiTrading67.com · Vertex Pharmaceuticals Incorporated (VRTX · ISIN US92532F1003)
Weekly Structure
At 22/30 structure is solid: moving averages aligned and underlying trend intact.
Daily Momentum
At 13/35 momentum is weak: uncertain push and ill-defined direction.
Weekly Ichimoku
At 19/19 Ichimoku is fully bullish: above the cloud with Tenkan and Kijun aligned.
Daily CMF
At 3/6 CMF is neutral: balance between capital inflows and outflows.
Delta
At 3/10 the week is slightly negative: close between -2% and 0%.
Concise reading of each axis score · sum = IQS Lite (0-100)
Executive View
Our view last week
The stretched phase signals a cycle already extended, with daily MACD in strong bearish pressure and momentum under stress. The consolidation inside the NTZ remains interesting but requires awaiting confirmed breakout, with weekly Ichimoku supporting bullish dynamics. The view remains cautious until confirmed breakout.
This week's view by AiTrading67.com
Stretched phase with daily MACD in bearish fading and weekly Ichimoku above bullish cloud. Price compressed within NTZ awaiting breakout confirmation. Setup suggests dynamic neutrality: long trigger on confirmed break above 490.93.
Chart · 12-month trend
Charts provided by TradingView